年龄的到来:对orthoflaviviruses的mRNA疫苗
Fahima Akther1, Norbert Pardi2, David R Martinez3
1Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
Trends in immunology
|November 6, 2025
概括
通过脂质纳米颗粒 (LNP) 传递的信使RNA (mRNA) 疫苗代表了对抗蚊子和传播的orthoflaviviruses (如登革热和寨卡病毒) 的有希望的战略,提供了快速发展和广泛的保护.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗技术技术 疫苗技术
背景情况:
- 脊髓炎病毒 (例如登革热,寨卡病毒,黄热病) 是由蚊子和传播的重大公共卫生威胁.
- 这些病毒具有流行病的潜力,需要有效和快速部署的对策.
- 目前的疫苗策略面临的挑战是实现广泛和持久的保护,对不同的orthoflaviviruses.
研究的目的:
- 审查最近对orthoflaviviruses的mRNA疫苗技术的进展.
- 检查抗原设计和输送平台的创新,以提高疫苗的有效性.
- 评估mRNA疫苗提供广泛,安全和持久的防护与orthoflavivirus感染的潜力.
主要方法:
- 关于对正方体状病毒的mRNA疫苗开发的最新科学文献的综述.
- 在脂质纳米粒子 (LNP) 输送系统的创新分析.
- 评估新型抗原设计策略,以引起强大的免疫反应.
主要成果:
- 脂纳米颗粒 (LNP) 封装的核酸修饰的mRNA疫苗为传递病毒抗原编码mRNA提供了一个强大的平台.
- 这些合成疫苗简化了复杂的病毒葡萄糖蛋白的表达,并允许快速,可扩展的制造.
- 抗原设计和LNP输送方面的创新显示出,扩大针对多种正方体病毒的疫苗保护具有前途.
结论:
- mRNA疫苗技术为开发针对orthoflaviviruses的疫苗提供了一个强大而可适应的平台.
- 抗原设计和LNP输送方面的进展对于提高疫苗安全性,耐用性和保护范围至关重要.
- 这种方法具有显著的潜力,可以减轻正方形病毒流行病和流行病的影响.
相关概念视频
Leaky Scanning
5.6K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.6K
Vaccinations
51.2K
Overview
51.2K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
Microorganisms in Medicine and Therapeutics
922
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
922
RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K


